These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1642674)

  • 1. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 7th communication: in vitro metabolism.
    Yamada Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):507-12. PubMed ID: 1642674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
    Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 2nd communication: tissue distribution and whole-body autoradiography of imidapril in rats.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):466-74. PubMed ID: 1642669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 3rd communication: tissue accumulation after consecutive oral administration of [N-methyl-14C]-imidapril in rats.
    Yamada Y; Endo M; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):475-82. PubMed ID: 1642670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats.
    Endo M; Yamada Y; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):483-9. PubMed ID: 1642671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
    Kubo M; Fujitsuka T; Ishida R
    Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
    Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
    Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
    Ikeo T; Yabana H; Kurosawa H; Kaburaki M; Kikkawa K; Narita H; Murata S; Yamaguchi I
    Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
    Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
    Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
    Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
    Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imidapril, an angiotensin-converting enzyme inhibitor, on insulin sensitivity and responsiveness in streptozotocin-induced diabetic rats.
    Viana AY; Oshida Y; Han YQ; Koshinaka K; Sato Y
    Horm Metab Res; 2004 Jan; 36(1):34-8. PubMed ID: 14983404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea.
    Sakamoto K; Sugimoto K; Sudoh T; Fujimura A
    Hypertens Res; 2005 Mar; 28(3):243-7. PubMed ID: 16097368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-acting angiotensin-converting enzyme inhibitor, imidapril, on the lower limit of cerebral blood flow autoregulation in hypertensive rats.
    Cai H; Yao H; Ibayashi S; Zhao G; Kitazono T; Nagao T; Fujishima M
    Eur J Pharmacol; 1998 Jan; 341(1):73-7. PubMed ID: 9489858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of heparan sulfate in the renoprotective effects of imidapril, an angiotensin-converting enzyme inhibitor, in diabetic db/db mice.
    Yoneda H; Ueta K; Nagasaki M; Arakawa K
    J Recept Signal Transduct Res; 2014 Feb; 34(1):21-5. PubMed ID: 24094140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
    Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
    J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.